title: Prophylactic oseltamivir treatment for prevention of donor-recipient influenza A H1N1 virus transmission does not compromise stem cell mobilization or engraftment.
authors.forename: A
authors.initials: A
authors.lastname: Rohn
authors.forename: H H
authors.initials: HH
authors.lastname: Kessler
authors.forename: T
authors.initials: T
authors.lastname: Valentin
authors.forename: W
authors.initials: W
authors.lastname: Linkesch
authors.forename: P
authors.initials: P
authors.lastname: Neumeister
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D001782:Blood Donors; D005260:Female; D019650:Hematopoietic Stem Cell Mobilization; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype; D007251:Influenza, Human / Q000517:prevention & control* / Q000635:transmission; D008875:Middle Aged; D053139:Oseltamivir / Q000627:therapeutic use*; D036102:Peripheral Blood Stem Cell Transplantation / Q000009:adverse effects*
chemical_list: D000998:Antiviral Agents; D053139:Oseltamivir